Eye care products gave a boost to Allergan, as third-quarter sales in that division grew by 4.8 percent to $535.1 million, an 8 percent increase in constant currencies. The growth for the overall company was 4.2 percent to $1.13 billion, a 7 percent increase on a currency-neutral basis. Net earnings ...
Buying a membership today will give you:
To continue reading this article register now.